在心脏门手术中应用末期肝病模型作为疾病分类:基于INSPIRE数据库的回顾性研究
Wei Zhou1, Xiaobin Liu1, Xingping Lv1
1Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Journal of thoracic disease
|August 15, 2024
概括
末期肝病模型 (MELD) 评分有效预测心脏门手术患者的结果. 较高的MELD得分与增加的死亡率和并发症相关,突出显示了其在患者分层中的有用性.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 末期肝病模型 (MELD) 评分是脏,肝脏和心脏功能障碍的验证预测指标.
- 它在预测心脏门手术患者的结果中的实用性仍然是积极研究的领域.
研究的目的:
- 调查MELD得分与心脏门手术患者的临床结果之间的相关性.
- 评估MELD得分对该患者群体死亡率和发病率的预测价值.
主要方法:
- 从心脏门手术患者 (大动脉, mitra,三门) 的临床数据的回顾性分析.
- 利用INSPIRE数据库并进行ROC分析以确定MELD作为主要的评分工具.
- 将患者分层分为高 (MELD ≥18) 和低 (MELD <18) MELD评分组进行比较分析.
主要成果:
- 与低MELD组 (75.5%) 相比,高MELD组 (24.5%) 的BMI较低,紧急手术的发生率更高,手术时间更长 (麻醉,手术,CPB).
- 高MELD组的28天死亡率显著增加 (10.66%vs0.8%),住院和ICU停留时间更长,机械循环支持 (IABP,ECMO) 和CRRT的需求增加.
- 卡普兰-梅尔生存分析证实,低MELD组的死亡率显著降低 (P<0.001).
结论:
- MELD评分是心脏门手术患者临床结果的强有力的预测指标.
- 梅尔德得分作为一种有价值的指标,用于分层疾病严重程度和预测该队列的预后.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...